Diagnosis and treatment of peripheral arterial disease

American Family Physician

Volumn 88, Issue 5, 2013, Pages 306-310

  Hennion, Duane R ^a   Siano, Kelly A ^a  

^a TRIPLER ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CILOSTAZOL; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PENTOXIFYLLINE; PLACEBO; RAMIPRIL;

ANKLE BRACHIAL INDEX; ARTICLE; CLAUDICATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIFFERENTIAL DIAGNOSIS; DOPPLER FLOWMETRY; EXERCISE; HUMAN; INTERMITTENT CLAUDICATION; LIFESTYLE MODIFICATION; MAGNETIC RESONANCE ANGIOGRAPHY; PATIENT COUNSELING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCREENING; SMOKING CESSATION; SYSTEMATIC REVIEW (TOPIC);

EID: 84883861746     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Norgren L, Hiatt WR, Dormandy JA, et al.; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease. J Vasc Surg. 2007;45(suppl S):S5-S67.
2. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317-1324.
3. Pasternak RC, Criqui MH, Benjamin EJ, et al.; American Heart Association. Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology. Circulation. 2004;109(21):2605-2612.
4. Hirsch AT, Haskal ZJ, Hertzer NR, et al.; American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary. J Am Coll Cardiol. 2006;47(6):1239-1312.
5. Arain FA, Cooper LT Jr. Peripheral arterial disease: diagnosis and management. Mayo Clin Proc. 2008;83(8):944-949.
6. Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol. 2005;25(7):1463-1469.
7. 2011 Writing Group members; 2005 Writing Committee members; ACCF/AHA Task Force members. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline). Circulation. 2011;124(18):2020-2045.
8. Fowkes FG, Murray GD, Butcher I, et al.; Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300(2):197-208.
9. Moyer VA; U.S. Preventive Services Task Force. Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in U.S. adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;159(5):342-349.
10. American Diabetes Association. Peripheral arterial disease in people with diabetes. Clin Diabetes. 2004;22(4):181-189.
11. Criqui MH, Alberts MJ, Fowkes FG, et al.; American Heart Association Writing Group 2. Atherosclerotic Peripheral Vascular Disease Symposium II: screening for atherosclerotic vascular diseases: should nationwide programs be instituted? [published correction appears in Circulation. 2009;119(25):e604]. Circulation. 2008;118(25):2830-2836.
12. Lamina C, Meisinger C, Heid IM, et al.; Kora Study Group. Association of ankle-brachial index and plaques in the carotid and femoral arteries with cardiovascular events and total mortality in a population-based study with 13 years of follow-up. Eur Heart J. 2006;27(21):2580-2587.
13. Lin JS, Olson CM, Johnson ES, et al.; U.S. Preventive Services Task Force. The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013;159(5):online.
14. Watson L, Ellis B, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2008;8(4):CD000990.
15. Frans FA, Bipat S, Reekers JA, et al. Systematic review of exercise training or percutaneous transluminal angioplasty for intermittent claudication. Br J Surg. 2012;99(1):16-28.
16. Girolami B, Bernardi E, Prins MH, et al. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med. 1999;159(4):337-345.
17. Paraskevas KI, Wierzbicki AS, Mikhailidis DP. Statins and noncardiac vascular disease. Curr Opin Cardiol. 2012;27(4):392-397.
18. Mohler ER III, Hiatt WR, Creager MA. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation. 2003;108(12):1481-1486.
19. McDermott MM, Guralnik JM, Greenland P, et al. Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease. Circulation. 2003;107(5):757-761.
20. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348(9038):1329-1339.
21. Alonso-Coello P, Bellmunt S, McGorrian C, et al.; American College of Chest Physicians. Antithrombotic therapy in peripheral artery disease. Chest. 2012;141(2 suppl):e669S-e690S.
22. Pande RL, Hiatt WR, Zhang P, et al. A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication. Vasc Med. 2010;15(3):181-188.
23. Thompson PD, Zimet R, Forbes WP, et al. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol. 2002; 90(12):1314-1319.
24. Dawson DL, Cutler BS, Hiatt WR, et al. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med. 2000;109(7):523-530.
25. Ahimastos AA, Walker PJ, Askew C, et al. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. JAMA. 2013;309(5):453-460.
26. Weitz JI, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review [published correction appears in Circulation. 2000;102(9):1074]. Circulation. 1996;94(11):3026-3049.
27. O'Hare AM, Katz R, Shlipak MG, et al. Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation. 2006;113(3):388-393.